DaShenLin Pharmaceutical Group Co., Ltd. engages in the manufacture, distribution, and retail of pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and tonic herbs, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.
Research context
DaShenLin Pharmaceutical Group Co., Ltd appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
DaShenLin Pharmaceutical Group Co., Ltd is currently in a long term downtrend where the price is trading 28.5% below its 200 day moving average.
From a valuation standpoint, the stock is 55.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.3.
DaShenLin Pharmaceutical Group Co., Ltd's total revenue rose by 27.4% to $4B since the same quarter in the previous year.
Its net income has increased by 55.2% to $272M since the same quarter in the previous year.
Finally, its free cash flow grew by 41.3% to $688M since the same quarter in the previous year.
Based on the above factors, DaShenLin Pharmaceutical Group Co., Ltd gets an overall score of 4/5.